Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T17758 | Target Info | |||
Target Name | Urokinase-type plasminogen activator (PLAU) | ||||
Synonyms | UPA; U-plasminogen activator | ||||
Target Type | Successful Target | ||||
Gene Name | PLAU | ||||
Biochemical Class | Peptidase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 4-Bromobenzylamine | Ligand Info | |||
Canonical SMILES | C1=CC(=CC=C1CN)Br | ||||
InChI | 1S/C7H8BrN/c8-7-3-1-6(5-9)2-4-7/h1-4H,5,9H2 | ||||
InChIKey | XRNVSPDQTPVECU-UHFFFAOYSA-N | ||||
PubChem Compound ID | 77571 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 5YC6 The crystal structure of uPA in complex with 4-Bromobenzylamirne at pH4.6 | ||||||
Method | X-ray diffraction | Resolution | 1.18 Å | Mutation | No | [1] |
PDB Sequence |
IIGGEFTTIE
25 NQPWFAAIYR35 RHRGGSVTYV41 CGGSLISPCW51 VISATHCFID60A YPKKEDYIVY 67 LGRSRLNSNT77 QGEMKFEVEN87 LILHKDYSAD97 TLAHHNDIAL105 LKIRSKEGRC 111 AQPSRTIQTI121 ALPSMYNDPQ131 FGTSCEITGF141 GKEQSTDYLY151 PEQLKMTVVK 161 LISHRECQQP170A HYYGSEVTTK179 MLCAADPQWK187 TDSCQGDSGG197 PLVCSLQGRM 207 TLTGIVSWGR217 GCALKDKPGV227 YTRVSHFLPW237 IRSHTK
|
|||||
|
||||||
PDB ID: 5YC7 The crystal structure of uPA in complex with 4-Bromobenzylamirne at pH7.4 | ||||||
Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [1] |
PDB Sequence |
IIGGEFTTIE
25 NQPWFAAIYR35 RHRGGSVTYV41 CGGSLISPCW51 VISATHCFID60A YPKKEDYIVY 67 LGRSRLNSNT77 QGEMKFEVEN87 LILHKDYSAD97 TLAHHNDIAL105 LKIRSKEGRC 111 AQPSRTIQTI121 ALPSMYNDPQ131 FGTSCEITGF141 GKEQSTDYLY151 PEQLKMTVVK 161 LISHRECQQP170A HYYGSEVTTK179 MLCAADPQWK187 TDSCQGDSGG197 PLVCSLQGRM 207 TLTGIVSWGR217 GCALKDKPGV227 YTRVSHFLPW237 IRSHTK
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Halogen bonding for the design of inhibitors by targeting the S1 pocket of serine proteases. doi:10.1039/c8ra03145b. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.